| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Americas
1 company
James Conklin is EVP, Americas at ADNT. James Conklin's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.0M at current prices.
Historically, James Conklin's trades have earned a strong insider score of 70/100 across 3 rated trades. Over a 12-month horizon, all 3 of those trades were profitable, with an average 12-month return of +34.7%.
The ADNT filings lean toward selling, a net 15,901 shares.
James Conklin has 10 Form 4 filings on record from July 2023 to May 2026, all as EVP, Americas at Adient (ADNT), 2023–2026.
The 20 reported transactions were 11 tax withholdings, 6 stock awards and 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $396K.
The largest open-market sale was 11,500 shares of ADNT at an average $20.25 on December 4, 2024, about $233K. Twelve months later ADNT was down 7%.
2 of the 3 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other was not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2024 | ADNT Adient Plc | EVP, Americas | Sell | 11,500 | $20.25 | $232,875.00 | -18.2% | -30.7% | -6.6% | |
| Feb 12, 2024 | ADNT Adient Plc | EVP, Americas | Sell10b5-1 | 3,492 | $35.00 | $122,220.00 | -10.0% | -15.1% | -50.3% | |
| Aug 3, 2023 | ADNT Adient Plc | EVP, Americas | Sell10b5-1 | 909 | $45.00 | $40,905.00 | -4.8% | -24.7% | -47.2% |